Scispace (Formerly Typeset)
  1. Home
  2. Journals
  3. Journal of Experimental Medicine
  4. 2023
  1. Home
  2. Journals
  3. Journal of Experimental Medicine
  4. 2023
Showing papers in "Journal of Experimental Medicine in 2023"
Journal Article•10.1084/jem.20221007•
Macrophages promote anti-androgen resistance in prostate cancer bone disease

[...]

Xue-Feng Li, Cigdem Selli, Jian Cao, Shuiqing Wu, Ruoyu Ma, Ye Lu, Cheng-Bin Zhang, Bijie Xun, Alyson D. Lam, Xiaocong Pang, Anu Fernando, Zeda Zhang, Asier Unciti-Broceta, Neil O. Carragher, Prakash Ramachandran, Neil C. Henderson, Lingling Sun, Haiyan Hu, Gui-Bo Li, Charles L. Sawyers, Bin-Zhi Qian 
07 Feb 2023-Journal of Experimental Medicine
TL;DR: In this article , a new mechanism of macrophage-driven therapy resistance of metastatic prostate cancer with high ECM expression and SRC activation using a novel in vivo model of bone-metastastic prostate cancer was proposed.
Abstract: New mechanism of macrophage-driven therapy resistance of metastatic prostate cancer with high ECM expression and SRC activation using a novel in vivo model of bone-metastatic prostate cancer.

59 citations

Journal Article•10.1084/jem.20221755•
Human germline heterozygous gain-of-function<i>STAT6</i>variants cause severe allergic disease

[...]

08 Mar 2023-Journal of Experimental Medicine
TL;DR: In this paper , the authors identified 16 patients from 10 families spanning three continents with a profound phenotype of early-life onset allergic immune dysregulation, widespread treatment-resistant atopic dermatitis, hypereosinophilia with esinophilic gastrointestinal disease, asthma, elevated serum IgE, IgE-mediated food allergies, and anaphylaxis.
Abstract: STAT6 (signal transducer and activator of transcription 6) is a transcription factor that plays a central role in the pathophysiology of allergic inflammation. We have identified 16 patients from 10 families spanning three continents with a profound phenotype of early-life onset allergic immune dysregulation, widespread treatment-resistant atopic dermatitis, hypereosinophilia with esosinophilic gastrointestinal disease, asthma, elevated serum IgE, IgE-mediated food allergies, and anaphylaxis. The cases were either sporadic (seven kindreds) or followed an autosomal dominant inheritance pattern (three kindreds). All patients carried monoallelic rare variants in STAT6 and functional studies established their gain-of-function (GOF) phenotype with sustained STAT6 phosphorylation, increased STAT6 target gene expression, and TH2 skewing. Precision treatment with the anti–IL-4Rα antibody, dupilumab, was highly effective improving both clinical manifestations and immunological biomarkers. This study identifies heterozygous GOF variants in STAT6 as a novel autosomal dominant allergic disorder. We anticipate that our discovery of multiple kindreds with germline STAT6 GOF variants will facilitate the recognition of more affected individuals and the full definition of this new primary atopic disorder.

57 citations

Journal Article•10.1084/jem.20221751•
Neutrophil extracellular traps and extracellular histones potentiate IL-17 inflammation in periodontitis.

[...]

Tae Sung Kim, Lakmali Munasinghage Silva, Vasileios Ionas Theofilou, Teresa Greenwell-Wild, Lu Li, Tomoko Ikeuchi, Laurie Brenchley, Thomas H. Bugge, Patricia Diaz, Mariana J. Kaplan, Carmelo Carmona-Rivera, Niki M. Moutsopoulos 
01 Jun 2023-Journal of Experimental Medicine
TL;DR: In this article , neutrophils infiltrate the gingival oral mucosa at early time points after disease induction and expel extracellular traps (NETs) to trigger mucosal inflammation and bone destruction in vivo.
Abstract: Neutrophil infiltration is a hallmark of periodontitis, a prevalent oral inflammatory condition in which Th17-driven mucosal inflammation leads to destruction of tooth-supporting bone. Herein, we document that neutrophil extracellular traps (NETs) are early triggers of pathogenic inflammation in periodontitis. In an established animal model, we demonstrate that neutrophils infiltrate the gingival oral mucosa at early time points after disease induction and expel NETs to trigger mucosal inflammation and bone destruction in vivo. Investigating mechanisms by which NETs drive inflammatory bone loss, we find that extracellular histones, a major component of NETs, trigger upregulation of IL-17/Th17 responses, and bone destruction. Importantly, human findings corroborate our experimental work. We document significantly increased levels of NET complexes and extracellular histones bearing classic NET-associated posttranslational modifications, in blood and local lesions of severe periodontitis patients, in the absence of confounding disease. Our findings suggest a feed-forward loop in which NETs trigger IL-17 immunity to promote immunopathology in a prevalent human inflammatory disease.

56 citations

Journal Article•10.1084/jem.20220525•
Stunning of neutrophils accounts for the anti-inflammatory effects of clodronate liposomes.

[...]

Stephan Culemann, Katharina Knab, Maximilien Euler, Jochen A. Ackermann, Kim Fischer, Deborah Kienhöfer, Georgiana Crainiciuc, Jonas Hahn, Anika Grüneboom, Falk Nimmerjahn, Stefan Uderhardt, Andrés Hidalgo, Georg Schett, Markus Hoffmann, Gerhard Krönke 
28 Mar 2023-Journal of Experimental Medicine
TL;DR: The authors revisited the effects of Clo-Lip together with genetic models of mononuclear phagocyte deficiency, revealing that Clo-lips exert their anti-inflammatory effects independent of MoPh.
Abstract: Clodronate liposomes (Clo-Lip) have been widely used to deplete mononuclear phagocytes (MoPh) to study the function of these cells in vivo. Here, we revisited the effects of Clo-Lip together with genetic models of MoPh deficiency, revealing that Clo-Lip exert their anti-inflammatory effects independent of MoPh. Notably, not only MoPh but also polymorphonuclear neutrophils (PMN) ingested Clo-Lip in vivo, which resulted in their functional arrest. Adoptive transfer of PMN, but not of MoPh, reversed the anti-inflammatory effects of Clo-Lip treatment, indicating that stunning of PMN rather than depletion of MoPh accounts for the anti-inflammatory effects of Clo-Lip in vivo. Our data highlight the need for a critical revision of the current literature on the role of MoPh in inflammation.

52 citations

Journal Article•10.1084/jem.20221094•
T helper 2 cells in asthma

[...]

James A. Harker, Clare M. Lloyd
10 May 2023-Journal of Experimental Medicine
TL;DR: Harker and Lloyd as mentioned in this paper reviewed the multifaceted roles of Th2 cells in human asthma, highlighting their influence of tissue location and disease severity, and explored how Th 2 cells and their cytokines have been targeted for biologic therapies for asthma patients.
Abstract: Harker and Lloyd review the multifaceted roles of Th2 cells in human asthma, highlighting their influence of tissue location and disease severity. They also explore how Th2 cells and their cytokines have been targeted for biologic therapies for asthma patients.

52 citations

Journal Article•10.1084/jem.20220686•
STAT3 regulates CD8+ T cell differentiation and functions in cancer and acute infection.

[...]

Qinli Sun, Xiaohong Zhao, Ruifeng Li, Dingfeng Liu, Birui Pan, Bowen Xie, Xinxin Chi, Dong Li Cai, Peng Wei, Wei Xu, Kun Wei, Zixuan Zhao, Yujie Fu, Ling Ni, Chen Dong 
23 Jan 2023-Journal of Experimental Medicine
TL;DR: The role of STAT3 signaling in the development and function of terminally differentiated effector CD8+ T cells in acute infection was investigated in this paper , where it was found that STAT3 transcriptionally promotes the expression of effector function-related genes, while it suppresses those expressed by the progenitor Tex subset.
Abstract: In cancer, persistent antigens drive CD8+ T cell differentiation into exhausted progenitor (Texprog) and terminally exhausted (Texterm) cells. However, how the extrinsic and intrinsic regulatory mechanisms cooperate during this process still remains not well understood. Here, we found that STAT3 signaling plays essential roles in promoting intratumor Texterm cell development by enhancing their effector functions and survival, which results in better tumor control. In tumor microenvironments, STAT3 is predominantly activated by IL-10 and IL-21, but not IL-6. Besides, STAT3 also plays critical roles in the development and function of terminally differentiated effector CD8+ T cells in acute infection. Mechanistically, STAT3 transcriptionally promotes the expression of effector function-related genes, while it suppresses those expressed by the progenitor Tex subset. Moreover, STAT3 functions in collaboration with BATF and IRF4 to mediate chromatin activation at the effector gene loci. Thus, we have elucidated the roles of STAT3 signaling in terminally differentiated CD8+ T cell development, especially in cancer, which benefits the development of more effective immunotherapies against tumors.

50 citations

Journal Article•10.1084/jem.20230661•
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients

[...]

A Gervais, Francesca Rovida, Maria Antonietta Avanzini, Stefania Croce, Astrid Marchal, Shi Li, Alessandro Ferrari, Christian W. Thorball, Orianne Constant, Tom Le Voyer, Quentin Philippot, Jérémie Rosain, Micol Angelini, Lucy Bizien, Cristian Achille, Elisa Burdino, Irene Cassaniti, Daniele Lilleri, Chiara Fornara, Josè Camilla Sammartino, Danilo Cereda, Chiara Marrocu, Antonio Piralla, Carla Valsecchi, Stefano Ricagno, Paola Cogo, Olaf Neth, Monia Pacenti, Alessandro Sinigaglia, Marta Trevisan, Andrea Volpe, Antonio Marzollo, Francesca Conti, Tiziana Lazzarotto, Andrea Pession, Pierluigi Viale, Jacques Fellay, Stefano Ghirardello, Mélodie Aubart, Valeria Ghisetti, Alessandro Aiuti, Emmanuelle Jouanguy, Paul Bastard, Elena Percivalle, Fausto Baldanti, Anne Puel, Margaret R. MacDonald, Charles M. Rice, Giada Rossini, Kristy O. Murray, Yannick Simonin, Anna Nagy, Luisa Barzon, Laurent Abel, Michael S. Diamond, Aurélie Cobat, Shen-ying Zhang, Jean-Laurent Casanova, Alessandro Borghesi 
22 Jun 2023-Journal of Experimental Medicine
TL;DR: Gervais et al. as mentioned in this paper showed that auto-Abs neutralizing type I IFNs and pre-existing infection underlie ∼40% of cases of West Nile virus (WNV) encephalitis.
Abstract: Gervais et al. show that auto-Abs neutralizing type I IFNs and pre-existing infection underlie ∼40% of cases of West Nile virus (WNV) encephalitis. Blood and cerebrospinal fluid auto-Abs neutralize the protective activity of type I IFNs against WNV in vitro.

50 citations

Journal Article•10.1084/jem.20220776•
Vision rescue via unconstrained in vivo prime editing in degenerating neural retinas.

[...]

Huan Qin, Wenliang Zhang, Shiyao Zhang, Yuan Feng, Weihui Xu, Jia Qi, Qian Zhang, Chunxiu Xu, Shanshan Liu, Jia Bao Zhang, Yushuang Lei, Wanqin Liu, Shuyu Feng, Jingjing Wang, Xue-Yan Fu, Zifen Xu, Ping Li, Kai Yao 
01 May 2023-Journal of Experimental Medicine
TL;DR: In this article , a dual AAV system packaging PESpRY for the in vivo genome editing through a non-NGG PAM (GTG) was used to prevent vision loss caused by retinitis pigmentosa (RP) associated gene mutations via unconstrained in vivo prime editing.
Abstract: Retinitis pigmentosa (RP) is an inherited retinal dystrophy causing progressive and irreversible loss of retinal photoreceptors. Here, we developed a genome-editing tool characterized by the versatility of prime editors (PEs) and unconstrained PAM requirement of a SpCas9 variant (SpRY), referred to as PESpRY. The diseased retinas of Pde6b-associated RP mouse model were transduced via a dual AAV system packaging PESpRY for the in vivo genome editing through a non-NGG PAM (GTG). The progressing cell loss was reversed once the mutation was corrected, leading to substantial rescue of photoreceptors and production of functional PDE6β. The treated mice exhibited significant responses in electroretinogram and displayed good performance in both passive and active avoidance tests. Moreover, they presented an apparent improvement in visual stimuli-driven optomotor responses and efficiently completed visually guided water-maze tasks. Together, our study provides convincing evidence for the prevention of vision loss caused by RP-associated gene mutations via unconstrained in vivo prime editing in the degenerating retinas.

48 citations

Journal Article•10.1084/jem.20230570•
Landscape of mast cell populations across organs in mice and humans

[...]

Marie Tauber, L. Basso, Jeremy Martin, Guilhem R. Thierry, Raïssa Houmadi, Nadine Serhan, Camille Blériot, Jasper B. J. Kamphuis, Mirjana Grujic, Lena Kjellén, Gunnar Pejler, Carle Paul, Xinzhong Dong, Stephen J. Galli, Laurent L. Reber, Florent Ginhoux, Marc Bajénoff, Rebecca Gentek, Nicolas Gaudenzio 
18 Jul 2023-Journal of Experimental Medicine
TL;DR: Tauber et al. as discussed by the authors presented a pan-organ analysis of mast cells in mice and humans at steady state, revealing an unexpected heterogeneity of mast cell populations across tissues and species.
Abstract: Combining whole-tissue imaging and single-cell RNA sequencing datasets, Tauber et al. present a pan-organ analysis of mast cells in mice and humans at steady state, revealing an unexpected heterogeneity of mast cell populations across tissues and species.

45 citations

Journal Article•10.1084/jem.20221346•
Age-associated B cells are heterogeneous and dynamic drivers of autoimmunity in mice.

[...]

Kevin M. Nickerson, Shuchi Smita, Kenneth B. Hoehn, Anthony D. Marinov, Kayla B. Thomas, Justin T. Kos, Yi Yang, Sheldon I. Bastacky, Corey T. Watson, Steven H. Kleinstein, Mark J. Shlomchik 
24 Feb 2023-Journal of Experimental Medicine
TL;DR: In this paper , the authors found unexpected heterogeneity among ABC-like cells for expression of the integrins CD11b and CD11c, T-bet, and memory or plasmablast markers.
Abstract: Age-associated B cells (ABCs) are formed under inflammatory conditions and are considered a type of memory B cell (MBC) expressing the transcription factor T-bet. In SLE, ABC frequency is correlated with disease, and they are thought to be the source of autoantibody-secreting cells. However, in inflammatory conditions, whether autoreactive B cells can become resting MBCs is uncertain. Further, the phenotypic identity of ABCs and their relationship to other B cell subsets, such as plasmablasts, is unclear. Whether ABCs directly promote disease is untested. Here we report, in the MRL/lpr SLE model, unexpected heterogeneity among ABC-like cells for expression of the integrins CD11b and CD11c, T-bet, and memory or plasmablast markers. Transfer and labeling studies demonstrated that ABCs are dynamic, rapidly turning over. scRNA-seq identified B cell clones present in multiple subsets, revealing that ABCs can be plasmablast precursors or undergo cycles of reactivation. Deletion of CD11c-expressing B cells revealed a direct role for ABC-like B cells in lupus pathogenesis.

44 citations

Journal Article•10.1084/jem.20220990•
STING trafficking as a new dimension of immune signaling

[...]

Devon Jeltema, Kennady N. Abbott, Nan Yan
27 Jan 2023-Journal of Experimental Medicine
TL;DR: In this paper , the authors review how STING trafficking influences signaling, propose a model of tonic STING signaling, and discuss an emerging link between dysregulated STing trafficking and neurodegenerative disease.
Abstract: STING signaling is at the center of multiple autoinflammatory and neurodegenerative diseases. The authors review how STING trafficking influences signaling, propose a model of tonic STING signaling, and discuss an emerging link between dysregulated STING trafficking and neurodegenerative disease.
Journal Article•10.1084/jem.20222129•
CCL5-producing migratory dendritic cells guide CCR5+ monocytes into the draining lymph nodes

[...]

Kavita Rawat, Anita Tewari, Xin Li, Arlind B Mara, William T. King, Sophie L. Gibbings, Chinaza F Nnam, Fred W. Kolling, Bart N. Lambrecht, Claudia Jakubzick 
22 Mar 2023-Journal of Experimental Medicine
TL;DR: In this paper , both DCs and monocytes capture antigen for presentation to lymph node T cells and use the chemokine receptor CCR7, while monocytes follow chemokines secreted by migrating DCs to reach the nodes and control immunity.
Abstract: Both DCs and monocytes capture antigen for presentation to lymph node T cells. Here, Rawat et al. show that DCs use the chemokine receptor CCR7, while monocytes follow chemokines secreted by migratory DCs to reach the nodes and control immunity.
Journal Article•10.1084/jem.20221929•
Age-related alterations in meningeal immunity drive impaired CNS lymphatic drainage.

[...]

Justin Rustenhoven, Georgios Pavlou, Taitea Dykstra, Siling Du, Zhengpeng Wan, Joshua P. Scallan, Igor Smirnov, Roger D. Kamm, Jonathan Kipnis 
07 Apr 2023-Journal of Experimental Medicine
TL;DR: In this paper , a single-cell RNA sequencing of meningeal lymphatic endothelial cells from aged mice revealed their response to IFNγ, which was increased in the aged meninges due to T cell accumulation.
Abstract: The meningeal lymphatic network enables the drainage of cerebrospinal fluid (CSF) and facilitates the removal of central nervous system (CNS) waste. During aging and in Alzheimer's disease, impaired meningeal lymphatic drainage promotes the buildup of toxic misfolded proteins in the CNS. Reversing this age-related dysfunction represents a promising strategy to augment CNS waste clearance; however, the mechanisms underlying this decline remain elusive. Here, we demonstrate that age-related alterations in meningeal immunity underlie this lymphatic impairment. Single-cell RNA sequencing of meningeal lymphatic endothelial cells from aged mice revealed their response to IFNγ, which was increased in the aged meninges due to T cell accumulation. Chronic elevation of meningeal IFNγ in young mice via AAV-mediated overexpression attenuated CSF drainage-comparable to the deficits observed in aged mice. Therapeutically, IFNγ neutralization alleviated age-related impairments in meningeal lymphatic function. These data suggest manipulation of meningeal immunity as a viable approach to normalize CSF drainage and alleviate the neurological deficits associated with impaired waste removal.
Journal Article•10.1084/jem.20221156•
The Z-nucleic acid sensor ZBP1 in health and disease

[...]

Jonathan Maelfait, Jan Rehwinkel
14 Jul 2023-Journal of Experimental Medicine
TL;DR: ZBP1 is an innate immune sensor for double-stranded nucleic acids adopting the Z conformation as discussed by the authors , which is generated during viral infections and in autoinflammation and cancer.
Abstract: ZBP1 is an innate immune sensor for double-stranded nucleic acids adopting the Z conformation. Z-RNA/DNA is generated during viral infections and in autoinflammation and cancer. By inducing regulated cell death and proinflammatory signaling, ZBP1 plays multifaceted roles in disease pathology.
Journal Article•10.1084/jem.20221952•
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma

[...]

Irene L.M. Reijers, Disha Rao, Judith M. Versluis, Alexander M. Menzies, Petros Dimitriadis, Michel W.J.M. Wouters, Andrew J. Spillane, W. Martin C. Klop, Annegien Broeks, Linda J.W. Bosch, Marta Lopez-Yurda, W. van Houdt, Robert V. Rawson, Lindsay G Grijpink-Ongering, María Jesús González González, Sten Cornelissen, Jasper Bouwman, Joyce Sanders, Elsemieke I. Plasmeijer, Y.S. Elshot, Richard A. Scolyer, B. A. Van De Wiel, Daniel S. Peeper, Alexander C.J. van Akkooi, Georgina V. Long, Christian U. Blank 
15 Mar 2023-Journal of Experimental Medicine
TL;DR: In this article , a baseline IFN-γ signature enables prospective selection of patients who can benefit from anti-PD-1 monotherapy in the DONIMI trial, where domatinostat (a class I HDAC inhibitor) does not add benefit to neoadjuvant anti- PD-1 ± anti-CTLA-4 in patients.
Abstract: In the DONIMI trial, a baseline IFN-γ signature enables prospective selection of patients who can benefit from anti-PD-1 monotherapy. In contrast to results of our murine melanoma model, domatinostat (a class I HDAC inhibitor) does not add benefit to neoadjuvant anti-PD-1 ± anti-CTLA-4 in patients.
Journal Article•10.1084/jem.20220170•
Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia

[...]

Ana García-García, Rebeca Pérez de Diego, Carlos Flores, Darawan Rinchai, Jordi Solé-Violán, Angela Deyà-Martínez, Blanca García-Solís, José M. Lorenzo-Salazar, Elisa Hernández-Brito, Anna Lanz, Leen Moens, Giorgia Bucciol, Mohamed A Almuqamam, Joseph B. Domachowske, Elena Colino, Juan Luis Santos-Perez, Francisco Marco, Claudio Pignata, Aziz Bousfiha, Stuart E. Turvey, S. Baur, Filomeen Haerynck, Javier Gonzalo Ocejo-Vinyals, Francisco Lendínez, Seraina Prader, Nora Naumann-Bartsch, Jana Pachlopnik Schmid, Catherine M. Biggs, Kyla J. Hildebrand, Alexandra Dreesman, Miguel Angel Cárdenes, Fatima Ailal, Ibtihal Benhsaien, Giuliana Giardino, Águeda Molina-Fuentes, Claudia Fortuny, Swetha Madhavarapu, Daniel H. Conway, Carolina Prando, Laire Schidlowski, María Teresa Martínez de Saavedra Álvarez, Rafael Alfaro, Felipe Rodríguez de Castro, Isabelle Meyts, Fabian Hauck, Anne Puel, Paul Bastard, Bertrand Boisson, Emmanuelle Jouanguy, Laurent Abel, Aurélie Cobat, Qian Zhang, Jean-Laurent Casanova, Laia Alsina, Carlos Rodríguez-Gallego 
03 Mar 2023-Journal of Experimental Medicine
TL;DR: MyD88 and IRAK-4-deficient patients have a higher risk of hypoxemic COVID-19 pneumonia than individuals of similar age in the general population, due to impaired TLR7-dependent type I IFN production as mentioned in this paper .
Abstract: MyD88- and IRAK-4–deficient patients have a higher risk of hypoxemic COVID-19 pneumonia than individuals of similar age in the general population, due to impaired TLR7-dependent type I IFN production.
Journal Article•10.1084/jem.20220741•
Immune-interacting lymphatic endothelial subtype at capillary terminals drives lymphatic malformation

[...]

Milena Petkova, Marle Kraft, Simon Stritt, Ines Martinez-Corral, Henrik Ortsäter, Michael Vanlandewijck, Bojana Jakic, Eulalia Baselga, Sandra Castillo, Mariona Graupera, Christer Betsholtz, Taija Mäkinen 
23 Jan 2023-Journal of Experimental Medicine
TL;DR: Petkova et al. as mentioned in this paper identified a new Ptx3-positive immune-interacting subtype of lymphatic endothelial cells, iLECs, that drive oncogenic PI3K-driven lymphatic malformations.
Abstract: Petkova et al. identify a new Ptx3-positive immune-interacting subtype of lymphatic endothelial cells, iLECs, that drive oncogenic PI3K-driven lymphatic malformations. These cells produce chemokines that recruit pro-lymphangiogenic macrophages, which in turn promote pathological lymphatic vessel growth.
Journal Article•10.1084/jem.20230707•
CD8+ lymphocytes are critical for early control of tuberculosis in macaques.

[...]

Caylin G. Winchell1, Sarah K. Nyquist2, Michael C Chao, Pauline Maiello1, Amy J. Myers1, Forrest F. Hopkins3, Mike Chase, Hannah P. Gideon1, K V Patel, Joshua D. Bromley, Andrew W. Simonson4, Roisin Floyd-O'Sullivan, Marc H. Wadsworth5, Jacob M Rosenberg, R. Uddin, Travis Hughes, Ryan J Kelly, Josephine Griffo, Jaime Tomko1, Edwin Klein1, Bonnie Berger, Charles A. Scanga1, Joshua T. Mattila1, Sarah Fortune, Alex K. Shalek5, Philana Ling Lin1, JoAnne L. Flynn •
University of Pittsburgh1, Ragon Institute of MGH, MIT and Harvard2, Harvard University3, Pennsylvania State University4, Massachusetts Institute of Technology5
16 Oct 2023-Journal of Experimental Medicine
TL;DR: Analysis of barcoded Mtb from infected macaques demonstrated that depletion of all CD8+ lymphocytes allowed increased establishment of Mtb in lungs and dissemination within lungs and to lymph nodes, while depletion of only adaptiveCD8+ T cells (with anti-CD8β antibody) worsened bacterial control in lymph nodes.
Abstract: The functional role of CD8+ lymphocytes in tuberculosis remains poorly understood. We depleted innate and/or adaptive CD8+ lymphocytes in macaques and showed that loss of all CD8α+ cells (using anti-CD8α antibody) significantly impaired early control of Mycobacterium tuberculosis (Mtb) infection, leading to increased granulomas, lung inflammation, and bacterial burden. Analysis of barcoded Mtb from infected macaques demonstrated that depletion of all CD8+ lymphocytes allowed increased establishment of Mtb in lungs and dissemination within lungs and to lymph nodes, while depletion of only adaptive CD8+ T cells (with anti-CD8β antibody) worsened bacterial control in lymph nodes. Flow cytometry and single-cell RNA sequencing revealed polyfunctional cytotoxic CD8+ lymphocytes in control granulomas, while CD8-depleted animals were unexpectedly enriched in CD4 and γδ T cells adopting incomplete cytotoxic signatures. Ligand-receptor analyses identified IL-15 signaling in granulomas as a driver of cytotoxic T cells. These data support that CD8+ lymphocytes are required for early protection against Mtb and suggest polyfunctional cytotoxic responses as a vaccine target.
Journal Article•10.1084/jem.20230447•
Mammalian infections with highly pathogenic avian influenza viruses renew concerns of pandemic potential.

[...]

Brad Gilbertson, Kanta Subbarao
16 Jun 2023-Journal of Experimental Medicine
TL;DR: In this article , the authors highlight the need to continually monitor and assess mammalian-origin H5N1 clade 2.3.4.4b viruses for the presence of mutations that could potentially increase their pandemic risk for humans.
Abstract: There is unprecedented spread of highly pathogenic avian influenza A H5N1 viruses in bird species on five continents, and many reports of infections in mammals most likely resulting from consumption of infected birds. As H5N1 viruses infect more species, their geographical range increases and more viral variants are produced that could have new biological properties including adaptation to mammals and potentially to humans. This highlights the need to continually monitor and assess mammalian-origin H5N1 clade 2.3.4.4b viruses for the presence of mutations that could potentially increase their pandemic risk for humans. Fortunately, to date there have been a limited number of human cases, but infection of mammals increases the opportunity for the virus to acquire mutations that enhance efficient infection, replication, and spread in mammals, properties that have not been seen in these viruses in the past.
Journal Article•10.1084/jem.20221105•
Inborn errors of human B cell development, differentiation, and function

[...]

Stuart G. Tangye, Tina Nguyen, Elissa K. Deenick, Vanessa L. Bryant, Cindy S. Ma 
05 Jun 2023-Journal of Experimental Medicine
TL;DR: The fundamental importance of the role of human B cells in host defense against infectious diseases has been established by the discovery of inborn errors of immunity that disrupt B cell development, differentiation, or function as discussed by the authors .
Abstract: The fundamental importance of the role of human B cells in host defense against infectious diseases has been established by the discovery of inborn errors of immunity that disrupt B cell development, differentiation, or function. These findings have laid the groundwork for understanding mechanisms of disease and revealing pathways to improve humoral immunity and treat disease.
Journal Article•10.1084/jem.20210923•
Retinoic acid signaling during priming licenses intestinal CD103+ CD8 TRM cell differentiation.

[...]

Zhijuan Qiu, Camille Khairallah, Timothy Chu, Jessica Nancy Imperato, Xinyuan Lei, Galina Romanov, Amha Atakilit, Lynn Puddington, Brian S. Sheridan 
21 Feb 2023-Journal of Experimental Medicine
TL;DR: In this article , the authors demonstrate that T cell priming in the mesenteric lymph nodes (MLN) regulates CD103+ TRM cell differentiation in the intestine, and that T cells primed in the spleen were impaired in the ability to differentiate into CD103 + TRM cells after entry into the intestine.
Abstract: CD8 tissue-resident memory T (TRM) cells provide frontline protection at barrier tissues; however, mechanisms regulating TRM cell development are not completely understood. Priming dictates the migration of effector T cells to the tissue, while factors in the tissue induce in situ TRM cell differentiation. Whether priming also regulates in situ TRM cell differentiation uncoupled from migration is unclear. Here, we demonstrate that T cell priming in the mesenteric lymph nodes (MLN) regulates CD103+ TRM cell differentiation in the intestine. In contrast, T cells primed in the spleen were impaired in the ability to differentiate into CD103+ TRM cells after entry into the intestine. MLN priming initiated a CD103+ TRM cell gene signature and licensed rapid CD103+ TRM cell differentiation in response to factors in the intestine. Licensing was regulated by retinoic acid signaling and primarily driven by factors other than CCR9 expression and CCR9-mediated gut homing. Thus, the MLN is specialized to promote intestinal CD103+ CD8 TRM cell development by licensing in situ differentiation.
Journal Article•10.1084/jem.20221472•
Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages.

[...]

Michael A. Gonzalez, Daniel R. Lu, Maryam Yousefi, Ashley Kroll, Chen Hao Lo, Carlos G. Briseño, J. E. Vivienne Watson, Sergey V. Novitskiy, Vanessa Arias, Hong Zhou, Min K. Tsai, Emily Ashkin, Christopher W. Murray, Chi Ming Li, Monte M. Winslow, Kristin V. Tarbell 
05 Jun 2023-Journal of Experimental Medicine
TL;DR: In this article , the authors utilized both syngeneic and novel autochthonous lung tumor models in which neoplastic cells expressed the fluorophore tdTomato (tdTom) to identify TAMs that have phagocytosed neplastic cells in vivo.
Abstract: Phagocytosis is a key macrophage function, but how phagocytosis shapes tumor-associated macrophage (TAM) phenotypes and heterogeneity in solid tumors remains unclear. Here, we utilized both syngeneic and novel autochthonous lung tumor models in which neoplastic cells express the fluorophore tdTomato (tdTom) to identify TAMs that have phagocytosed neoplastic cells in vivo. Phagocytic tdTompos TAMs upregulated antigen presentation and anti-inflammatory proteins, but downregulated classic proinflammatory effectors compared to tdTomneg TAMs. Single-cell transcriptomic profiling identified TAM subset-specific and common gene expression changes associated with phagocytosis. We uncover a phagocytic signature that is predominated by oxidative phosphorylation (OXPHOS), ribosomal, and metabolic genes, and this signature correlates with worse clinical outcome in human lung cancer. Expression of OXPHOS proteins, mitochondrial content, and functional utilization of OXPHOS were increased in tdTompos TAMs. tdTompos tumor dendritic cells also display similar metabolic changes. Our identification of phagocytic TAMs as a distinct myeloid cell state links phagocytosis of neoplastic cells in vivo with OXPHOS and tumor-promoting phenotypes.
Journal Article•10.1084/jem.20221524•
MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition

[...]

Mark R. Silvis, Dilru Silva, Riley Rohweder, Sophia S. Schuman, Swapna Aravind Gudipaty, Amanda Truong, Jeffrey T. Yap, Kajsa E. Affolter, Martin McMahon, Conan G. Kinsey 
31 Jan 2023-Journal of Experimental Medicine
TL;DR: In this paper , CDK4/6 and lysosome function overcomes c-MYC-mediated cell cycle entry in the face of trametinib and chloroquine co-treatment in pancreatic cancer.
Abstract: Inhibition of CDK4/6 and lysosome function overcomes c-MYC–mediated cell cycle entry in the face of trametinib and chloroquine co-treatment in pancreatic cancer.
Journal Article•10.1084/jem.20230105•
Diphtheria toxin activates ribotoxic stress and NLRP1 inflammasome-driven pyroptosis.

[...]

Kim S. Robinson1, Gee Ann Toh2, Muhammad Jasrie Firdaus3, Khek-Chian Tham3, Pritisha Rozario4, Chrissie Lim3, Ying Xiu Toh3, Zhi Heng Lau, Sophie Charlotte Binder, Jacob Mayer, Carine Bonnard3, Florian I. Schmidt5, John E.A. Common3, Franklin L. Zhong2 •
University of Dundee1, Nanyang Technological University2, Agency for Science, Technology and Research3, National University of Singapore4, University of Bonn5
02 Oct 2023-Journal of Experimental Medicine
TL;DR: Diphtheria toxin triggers ribotoxic stress and NLRP1 inflammasome activation in human keratinocytes, leading to pyroptosis and IL-1β/IL-18 secretion, which is mediated by ZAKα and diphthamide synthesis, and can be inhibited by ZAKα pharmacology.
Abstract: The ZAKα-driven ribotoxic stress response (RSR) is activated by ribosome stalling and/or collisions. Recent work demonstrates that RSR also plays a role in innate immunity by activating the human NLRP1 inflammasome. Here, we report that ZAKα and NLRP1 sense bacterial exotoxins that target ribosome elongation factors. One such toxin, diphtheria toxin (DT), the causative agent for human diphtheria, triggers RSR-dependent inflammasome activation in primary human keratinocytes. This process requires iron-mediated DT production in the bacteria, as well as diphthamide synthesis and ZAKα/p38-driven NLRP1 phosphorylation in host cells. NLRP1 deletion abrogates IL-1β and IL-18 secretion by DT-intoxicated keratinocytes, while ZAKα deletion or inhibition additionally limits both pyroptotic and inflammasome-independent non-pyroptotic cell death. Consequently, pharmacologic inhibition of ZAKα is more effective than caspase-1 inhibition at protecting the epidermal barrier in a 3D skin model of cutaneous diphtheria. In summary, these findings implicate ZAKα-driven RSR and the NLRP1 inflammasome in antibacterial immunity and might explain certain aspects of diphtheria pathogenesis.
Journal Article•10.1084/jem.20220948•
Microbiome influencers of checkpoint blockade–associated toxicity

[...]

Yinghong Wang, Robert R. Jenq, Jennifer A. Wargo, Stephanie S. Watowich
09 Jan 2023-Journal of Experimental Medicine
TL;DR: Wang et al. as discussed by the authors discuss the contribution of the microbiome to immune-related adverse events (irAEs) with checkpoint inhibitors, focusing on major bacterial taxa, potential immune mechanisms, and clinical opportunities for microbiome modulation to treat irAEs.
Abstract: The microbiome influences response to immunotherapy, including immune-related adverse events (irAEs) with checkpoint inhibitors. Wang, Jenq, et al. discuss microbiome contributions to irAEs by focusing on major bacterial taxa, potential immune mechanisms, and clinical opportunities for microbiome modulation to treat irAEs.
Journal Article•10.1084/jem.20221212•
Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight.

[...]

Imran Howell, Aleksandra Howell, Ian D. Pavord
03 Jul 2023-Journal of Experimental Medicine
TL;DR: The field of asthma has undergone a dramatic change in recent years and advances in our understanding of type 2 airway inflammation have driven the discovery of monoclonal antibodies targeting specific aspects of the immune pathway as mentioned in this paper .
Abstract: The field of asthma has undergone a dramatic change in recent years. Advances in our understanding of type 2 airway inflammation have driven the discovery of monoclonal antibodies targeting specific aspects of the immune pathway. In landmark trials, these drugs have shown efficacy in reducing asthma attacks and exposure to oral corticosteroids, important causes of morbidity in people with asthma. Our review explores the key features of type 2 inflammation in asthma and summarizes the clinical trial evidence of the novel monoclonal antibody treatments and future avenues for treatment.
Journal Article•10.1084/jem.20221392•
Spatial mapping reveals granuloma diversity and histopathological superstructure in human tuberculosis.

[...]

Andrew J. Sawyer, Ellis Patrick, Jarem Edwards, James S. Wilmott, Timothy Fielder, Qianting Yang, Daniel L. Barber, Joel D. Ernst, Warwick J. Britton, Umaimainthan Palendira, Xinchun Chen, Carl G. Feng 
15 Mar 2023-Journal of Experimental Medicine
TL;DR: In this paper , the authors report that the human TB lung contains abundant non-necrotizing leukocyte aggregates surrounding areas of necrotizing tissue. And they show that during TB, diseased lung tissue develops a histopathological superstructure comprising at least four different types of non-neurotizing cellular aggregates organized as satellites of the granulomas.
Abstract: The hallmark of tuberculosis (TB) is the formation of immune cell-enriched aggregates called granulomas. While granulomas are pathologically diverse, their tissue-wide heterogeneity has not been spatially resolved at the single-cell level in human tissues. By spatially mapping individual immune cells in every lesion across entire tissue sections, we report that in addition to necrotizing granulomas, the human TB lung contains abundant non-necrotizing leukocyte aggregates surrounding areas of necrotizing tissue. These cellular lesions were more diverse in composition than necrotizing lesions and could be stratified into four general classes based on cellular composition and spatial distribution of B cells and macrophages. The cellular composition of non-necrotizing structures also correlates with their proximity to necrotizing lesions, indicating these are foci of distinct immune reactions adjacent to necrotizing granulomas. Together, we show that during TB, diseased lung tissue develops a histopathological superstructure comprising at least four different types of non-necrotizing cellular aggregates organized as satellites of necrotizing granulomas.
Journal Article•10.1084/jem.20230063•
Commensal bacteria promote type I interferon signaling to maintain immune tolerance in mice

[...]

Adriana Vasquez Ayala, C.-Y. Hsu, Renee E. Oles, Kazuhiko Matsuo, Luke R. Loomis, Ekaterina Buzun1, Marvic Carrillo Terrazas, Romana R. Gerner, Hsueh-Han Lu2, Sohee Kim, Ziyue Zhang, Jong Hwee Park, Paul Rivaud3, Matt Thomson, Li-Fan Lu, Booki Min, Hiutung Chu •
Newcastle University1, Academia Sinica2, California Institute of Technology3
12 Dec 2023-Journal of Experimental Medicine
TL;DR: The IFN gene signature in Tregs during inflammation highlights the role of the microbiota in maintaining tonic IFN to promote immune tolerance.
Abstract: Commensal bacteria, such as Bacteroides fragilis, triggers type I IFN and IL-27 in DCs to influence Tregs through IL27RA signaling. The IFN gene signature in Tregs during inflammation highlights the role of the microbiota in maintaining tonic IFN to promote immune tolerance.
Journal Article•10.1084/jem.20221388•
Trained immunity of alveolar macrophages enhances injury resolution via KLF4-MERTK-mediated efferocytosis

[...]

Sreeparna Chakraborty1, Abhalaxmi Singh2, Li Wang3, Xinge Wang4, Mark A. Sanborn5, Zijing Ye6, Mark Maienschein-Cline3, Amitabha Mukhopadhyay7, Balaji B. Ganesh3, Asrar B. Malik3, Jalees Rehman3 •
Bose Institute1, Nalco Holding Company2, University of Illinois at Chicago3, Fourth Military Medical University4, Walter Reed Army Institute of Research5, Illinois Institute of Technology6, Washington University in St. Louis7
24 Aug 2023-Journal of Experimental Medicine
TL;DR: Trained alveolar macrophages exhibit enhanced injury resolution via KLF4-MERTK-mediated efferocytosis, promoting a proresolving phenotype and restricting inflammatory lung injury in mice exposed to lethal pathogens.
Abstract: Recent studies suggest that training of innate immune cells such as tissue-resident macrophages by repeated noxious stimuli can heighten host defense responses. However, it remains unclear whether trained immunity of tissue-resident macrophages also enhances injury resolution to counterbalance the heightened inflammatory responses. Here, we studied lung-resident alveolar macrophages (AMs) prechallenged with either the bacterial endotoxin or with Pseudomonas aeruginosa and observed that these trained AMs showed greater resilience to pathogen-induced cell death. Transcriptomic analysis and functional assays showed greater capacity of trained AMs for efferocytosis of cellular debris and injury resolution. Single-cell high-dimensional mass cytometry analysis and lineage tracing demonstrated that training induces an expansion of a MERTKhiMarcohiCD163+F4/80low lung-resident AM subset with a proresolving phenotype. Reprogrammed AMs upregulated expression of the efferocytosis receptor MERTK mediated by the transcription factor KLF4. Adoptive transfer of these trained AMs restricted inflammatory lung injury in recipient mice exposed to lethal P. aeruginosa. Thus, our study has identified a subset of tissue-resident trained macrophages that prevent hyperinflammation and restore tissue homeostasis following repeated pathogen challenges.
Journal Article•10.1084/jem.20220509•
Obesity alters monocyte developmental trajectories to enhance metastasis.

[...]

Sheri A. C. McDowell, Simon Milette, Samuel Doré, Miranda W Yu, Mark Sorin, Lysanne Desharnais, Ozgun Varol, Anikka M. Swaby, Valérie Breton, Azadeh Arabzadeh, Sarah Petrecca, Aanya Bhagrath, Meghan L De Meo, Katherine D. Lach, Marianne Samir M. Issac, Benoit Fiset, Roni F. Rayes, Judith N. Mandl, Jörg H. Fritz, Pierre Olivier Fiset, Andrew J. Dannenberg, Jonathan Spicer, Logan A. Walsh, Daniela F. Quail 
11 May 2023-Journal of Experimental Medicine
TL;DR: In this paper , the authors show that obesity-induced monocytes underlie neutrophil activation and breast cancer lung metastasis and provide mechanistic insight into the relationship between obesity and cancer by broadening their understanding of the interactive role that myeloid cells play in this process.
Abstract: Obesity is characterized by chronic systemic inflammation and enhances cancer metastasis and mortality. Obesity promotes breast cancer metastasis to lung in a neutrophil-dependent manner; however, the upstream regulatory mechanisms of this process remain unknown. Here, we show that obesity-induced monocytes underlie neutrophil activation and breast cancer lung metastasis. Using mass cytometry, obesity favors the expansion of myeloid lineages while restricting lymphoid cells within the peripheral blood. RNA sequencing and flow cytometry revealed that obesity-associated monocytes resemble professional antigen-presenting cells due to a shift in their development and exhibit enhanced MHCII expression and CXCL2 production. Monocyte induction of the CXCL2-CXCR2 axis underlies neutrophil activation and release of neutrophil extracellular traps to promote metastasis, and enhancement of this signaling axis is observed in lung metastases from obese cancer patients. Our findings provide mechanistic insight into the relationship between obesity and cancer by broadening our understanding of the interactive role that myeloid cells play in this process.
...

Tools

SciSpace AgentBiomedical AgentSciSpace RecruitSciSpace for EnterpriseAgent GalleryChat with PDFLiterature ReviewAI WriterFind TopicsParaphraserCitation GeneratorExtract DataAI DetectorCitation Booster

Learn

ResourcesLive Workshops

SciSpace

CareersSupportBrowse PapersPricingSciSpace Affiliate ProgramCancellation & Refund PolicyTermsPrivacyData Sources

Directories

PapersTopicsJournalsAuthorsConferencesInstitutionsCitation StylesWriting templates

Extension & Apps

SciSpace Chrome ExtensionSciSpace Mobile App

Contact

support@scispace.com
SciSpace

© 2026 | PubGenius Inc. | Suite # 217 691 S Milpitas Blvd Milpitas CA 95035, USA

soc2
Secured by Delve